RedHill Biopharma Ltd. Share Price OTC Markets
Equities
REDIF
IL0011223810
Pharmaceuticals
Sales 2022 | 6.18Cr 516.13Cr | Sales 2023 | 65.3L 55Cr | Capitalization | 2.87Cr 239.9Cr |
---|---|---|---|---|---|
Net income 2022 | -7.1Cr -592.96Cr | Net income 2023 | 2.3Cr 192.09Cr | EV / Sales 2022 | 1.87 x |
Net Debt 2022 | 10Cr 857.78Cr | Net cash position 2023 | 43.96L 37Cr | EV / Sales 2023 | 3.73 x |
P/E ratio 2022 |
-0.12
x | P/E ratio 2023 |
0.4
x | Employees | 53 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 03/09/03 |
Ori Shilo
FOU | Founder | 58 | 03/09/03 |
Razi Ingber
DFI | Director of Finance/CFO | - | 05/23/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 01/16/01 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 26/10/26 |
Director/Board Member | 80 | 03/10/03 |
1st Jan change | Capi. | |
---|---|---|
+7.46% | 10TCr | |
+8.42% | 4.22TCr | |
-13.04% | 3.23TCr | |
+80.80% | 2.98TCr | |
-10.92% | 1.61TCr | |
+1.93% | 1.44TCr | |
-6.77% | 1.2TCr | |
+177.16% | 1.07TCr | |
+4.12% | 889.02Cr |